Civi Biopharma, Inc.

Quick facts

Phase 3 pipeline

• Iloprost Injection, for intravenous use · Cardiovascular
  Iloprost is a prostacyclin analog that binds to prostacyclin receptors on vascular endothelial and smooth muscle cells, promoting vasodilation and inhibiting platelet aggregation.

Phase 2 pipeline

• CIVI 007

Phase 1 pipeline

• CiVi007

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Civi Biopharma, Inc. portfolio CI brief
• Civi Biopharma, Inc. pipeline updates RSS